1988
DOI: 10.1073/pnas.85.12.4506
|View full text |Cite
|
Sign up to set email alerts
|

Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease.

Abstract: A substantially enriched preparation of Alzheimer paired helical filaments (PHFs) has been used as a starting point for biochemical studies. Pronase treatment, which strips off adhering proteins, leaves a resistant core that is structurally intact. This has been used to raise a monoclonal antibody that decorates the filament core. The antibody has been used to follow the extraction of two peptide fragments (9.5 and 12 kDa) by immunoblotting. The link between the PHF as a morphological entity and these peptides… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

11
611
0

Year Published

1990
1990
2019
2019

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 825 publications
(622 citation statements)
references
References 25 publications
11
611
0
Order By: Relevance
“…The data underscore the observations that the repeat domain forms the core of the PHFs (21,22), that the aggregation involves the generation of -structure (23,24), and that the N-and C-terminal flanking domains remain largely as an unstructured "fuzzy coat".…”
Section: Spectroscopy Of Alzheimer Phfs and In Vitro Reassembled Pmentioning
confidence: 57%
“…The data underscore the observations that the repeat domain forms the core of the PHFs (21,22), that the aggregation involves the generation of -structure (23,24), and that the N-and C-terminal flanking domains remain largely as an unstructured "fuzzy coat".…”
Section: Spectroscopy Of Alzheimer Phfs and In Vitro Reassembled Pmentioning
confidence: 57%
“…During the work providing molecular proof that microtubule associated protein tau is a major (if not sole) constituent of paired helical filaments [2,21], it was noted that tau could be truncated. Molecular mapping of the epitope of monoclonal antibody 423, that recognizes tau protein derived from AD brains, revealed for the first time that tau is truncated at E 391 in Alzheimer's disease [6,12].…”
Section: Discussionmentioning
confidence: 99%
“…There are several criteria for assessing the difference. (a) PHF tau is aggregated in an abnormal fashion; this effect is probably based on the repeat domain of tau [47,48]. (b) PHF tau has an abnormally high M, due to phosphorylation [6,10].…”
Section: Discussionmentioning
confidence: 99%